Spyre Therapeutics, Inc.盘中异动早盘大幅上涨5.30%报14.70美元

市场透视2025-04-23

北京时间2025年04月23日21时32分，Spyre Therapeutics, Inc.（SYRE.us）股票出现波动，股价急速拉升5.30%。截至发稿，该股报14.70美元/股，成交量1.1011万股，换手率0.02%，振幅1.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.50亿美元，每股收益-3.18美元，毛利0.00美元，市盈率-4.60倍。机构评级方面，在所有...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2529681759?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-04-23 21:32","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2529681759","market":"us","top_or_hot":-1,"title":"Spyre Therapeutics, Inc.盘中异动 早盘大幅上涨5.30%报14.70美元","media":"市场透视","content":"<div>\n<p>北京时间2025年04月23日21时32分，Spyre Therapeutics, Inc.（SYRE.us）股票出现波动，股价急速拉升5.30%。截至发稿，该股报14.70美元/股，成交量1.1011万股，换手率0.02%，振幅1.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.50亿美元，每股收益-3.18美元，毛利0.00美元，市盈率-4.60倍。机构评级方面，在所有...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213201aa2c7815&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Spyre Therapeutics, Inc.盘中异动 早盘大幅上涨5.30%报14.70美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSpyre Therapeutics, Inc.盘中异动 早盘大幅上涨5.30%报14.70美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-04-23 21:32 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213201aa2c7815&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2025年04月23日21时32分，Spyre Therapeutics, Inc.（SYRE.us）股票出现波动，股价急速拉升5.30%。截至发稿，该股报14.70美元/股，成交量1.1011万股，换手率0.02%，振幅1.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.50亿美元，每股收益-3.18美元，毛利0.00美元，市盈率-4.60倍。机构评级方面，在所有...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213201aa2c7815&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SYRE","symbol_name":"SPYRE THERAPEUTICS INC","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213201aa2c7815&s=b","article_id":"2529681759","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250423213201aa2c7815&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2529681759","pubTimestamp":1745415120,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2025年04月23日21时32分，Spyre Therapeutics, Inc.股票出现波动，股价急速拉升5.30%。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程、合理的治疗组合和用于患者选择的精准医学方法来创造下一代炎症性肠病  产品。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"SYRE":"SPYRE THERAPEUTICS INC","BK4007":"制药","LENZ":"Therapeutics","BK4139":"生物科技"},"translate_title":"Spyre Therapeutics, Inc. Intraday Movement Jumped 5.30% to $14.70 in Morning Trading","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SYRE":0.9,"LENZ":1},"content_text":"北京时间2025年04月23日21时32分，Spyre Therapeutics, Inc.（SYRE.us）股票出现波动，股价急速拉升5.30%。截至发稿，该股报14.70美元/股，成交量1.1011万股，换手率0.02%，振幅1.00%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-1.50亿美元，每股收益-3.18美元，毛利0.00美元，市盈率-4.60倍。机构评级方面，在所有11家参与评级的机构中，91%的券商给予买入建议，9%的券商给予持有建议，无券商给予卖出建议。Spyre Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Ensysce Biosciences, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025(To Pur Com)、Cero Therapeutics Holdings Inc C/Wts 13/02/2029 (To Pur Com)涨幅较大，Ensysce Biosciences, Inc.、Onconetix, Inc.、Ocean Biomedical, Inc.较为活跃，换手率分别为3040.41%、18.80%、8.51%，振幅较大的相关个股有Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025(To Pur Com)、Ensysce Biosciences, Inc.、Psyence Biomedical Ltd.，振幅分别为29.61%、28.87%、11.37%。Spyre Therapeutics, Inc.公司简介：Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程，合理的治疗组合和精确的医学方法来为患者选择，创造下一代炎症性肠病(IBD)产品。IBD是一种以胃肠道炎症为特征的慢性疾病，包括两种主要疾病：UC 和 CD。Spyre Therapeutics Inc 是一家生物技术公司，旨在通过结合抗体工程、合理的治疗组合和用于患者选择的精准医学方法来创造下一代炎症性肠病 （IBD） 产品。IBD 是一种以胃肠道炎症为特征的慢性疾病，包括 UC 和 CD 两种主要疾病。它有一个可报告的部门，即开发用于治疗 IBD 和其他免疫介导疾病患者的生物制药产品。它有一个可报告的部门，即开发用于治疗 IBD 和其他免疫介导疾病患者的生物制药产品。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2529681759","isCrawlerRequest":true}

Spyre Therapeutics, Inc.盘中异动 早盘大幅上涨5.30%报14.70美元

精彩评论

Spyre Therapeutics, Inc.盘中异动早盘大幅上涨5.30%报14.70美元